Chronic kidney disease enhances alternative pathway activity: a new paradigm

Overview of attention for article published in Journal of Clinical Investigation, May 2025

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

twitter: 5 X users

bluesky: 11 Bluesky users

Readers on

mendeley: 14 Mendeley

So far, Altmetric has seen 11 Bluesky posts from 11 Bluesky users, with an upper bound of 32,754 followers.

RP @madmarasa.bsky.social: Alternative complement pathway dysregulation in CKD and CKD progression, endothelial inflammation and cardiovascular outcomes… room for complement inhibitors beyond complement-mediated kidney diseases? www.jci.org/articles/vie…

Alternative complement pathway dysregulation in CKD and CKD progression, endothelial inflammation and cardiovascular outcomes… room for complement inhibitors beyond complement-mediated kidney diseases? www.jci.org/articles/vie... #NephSky #MedSky https…

Review @jclinical-invest.bsky.social Chronic kidney disease enhances alternative pathway activity: a new paradigm www.jci.org/articles/vie...

JCI - Chronic kidney disease enhances alternative pathway activity: a new paradigm www.jci.org/articles/vie...

This page shows the most recent Bluesky posts that mention this research output. Click here to find out how to access more activity, including 7 additional Bluesky posts.